155 related articles for article (PubMed ID: 32478898)
1. TEG PlateletMapping assay results may be misleading in the presence of cold stored platelets.
Scorer TG; FitzGibbon L; Aungraheeta R; Sharma U; Peltier GC; McIntosh CS; Reddoch-Cardenas KM; Meyer A; Cap AP; Mumford AD
Transfusion; 2020 Jun; 60 Suppl 3():S119-S123. PubMed ID: 32478898
[TBL] [Abstract][Full Text] [Related]
2. Comparative in vitro efficacy of different platelet glycoprotein IIb/IIIa antagonists on platelet-mediated clot strength induced by tissue factor with use of thromboelastography: differentiation among glycoprotein IIb/IIIa antagonists.
Mousa SA; Khurana S; Forsythe MS
Arterioscler Thromb Vasc Biol; 2000 Apr; 20(4):1162-7. PubMed ID: 10764688
[TBL] [Abstract][Full Text] [Related]
3. Glycoprotein IIb/IIIa and P2Y12 receptor antagonists yield additive inhibition of platelet aggregation, granule secretion, soluble CD40L release and procoagulant responses.
Judge HM; Buckland RJ; Holgate CE; Storey RF
Platelets; 2005 Nov; 16(7):398-407. PubMed ID: 16236601
[TBL] [Abstract][Full Text] [Related]
4. Value of thromboelastography in the assessment of platelet function.
Bowbrick VA; Mikhailidis DP; Stansby G
Clin Appl Thromb Hemost; 2003 Apr; 9(2):137-42. PubMed ID: 12812383
[TBL] [Abstract][Full Text] [Related]
5. Cold stored platelets in the management of bleeding: is it about bioenergetics?
George CE; Saunders CV; Morrison A; Scorer T; Jones S; Dempsey NC
Platelets; 2023 Dec; 34(1):2188969. PubMed ID: 36922733
[TBL] [Abstract][Full Text] [Related]
6. Cold temperatures reduce the sensitivity of stored platelets to disaggregating agents.
Mondoro TH; Vostal JG
Platelets; 2002 Feb; 13(1):11-20. PubMed ID: 11918832
[TBL] [Abstract][Full Text] [Related]
7. FcgammaRII mediates platelet aggregation caused by disintegrins and GPIIb/IIIa monoclonal antibody, AP2.
Huang TF; Chang CH; Ho PL; Chung CH
Exp Hematol; 2008 Dec; 36(12):1704-13. PubMed ID: 18809237
[TBL] [Abstract][Full Text] [Related]
8. Use of Specialized Pro-Resolving Mediators to Alleviate Cold Platelet Storage Lesion.
Reddoch-Cardenas KM; Sharma U; Salgado CL; Cantu C; Darlington DN; Pidcoke HF; Bynum JA; Cap AP
Transfusion; 2020 Jun; 60 Suppl 3():S112-S118. PubMed ID: 32478925
[TBL] [Abstract][Full Text] [Related]
9. In vitro measurement of platelet glycoprotein IIb/IIIa receptor blockade by abciximab: interindividual variation and increased platelet secretion.
Rossi F; Rossi E; Pareti FI; Colli S; Tremoli E; Gallo L
Haematologica; 2001 Feb; 86(2):192-8. PubMed ID: 11224490
[TBL] [Abstract][Full Text] [Related]
10. [Role of platelets aggregation in the process of ductus arteriosus closure of newborn pups].
Ren Y; Gao X; Zhao D; Wang L; Huang D; Su M
Zhonghua Wei Zhong Bing Ji Jiu Yi Xue; 2022 Nov; 34(11):1194-1199. PubMed ID: 36567565
[TBL] [Abstract][Full Text] [Related]
11. Anticoagulation during cardiopulmonary bypass in patients with heparin-induced thrombocytopenia type II and renal impairment using heparin and the platelet glycoprotein IIb-IIIa antagonist tirofiban.
Koster A; Kukucka M; Bach F; Meyer O; Fischer T; Mertzlufft F; Loebe M; Hetzer R; Kuppe H
Anesthesiology; 2001 Feb; 94(2):245-51. PubMed ID: 11176088
[TBL] [Abstract][Full Text] [Related]
12. Pharmacodynamic characterization of the interaction between abciximab or tirofiban with unfractionated or a low molecular weight heparin in healthy subjects.
Klinkhardt U; Graff J; Westrup D; Kirchmaier CM; Esslinger HU; Breddin HK; Harder S
Br J Clin Pharmacol; 2001 Sep; 52(3):297-305. PubMed ID: 11560562
[TBL] [Abstract][Full Text] [Related]
13. Effect of Ca2+ chelation on the platelet inhibitory ability of the GPIIb/IIIa antagonists abciximab, eptifibatide and tirofiban.
Marciniak SJ; Jordan RE; Mascelli MA
Thromb Haemost; 2001 Mar; 85(3):539-43. PubMed ID: 11307828
[TBL] [Abstract][Full Text] [Related]
14. Effects Of Glycoprotein IIb/IIIa Antagonists: Anti Platelet Aggregation And Beyond.
Giordano A; Musumeci G; D'Angelillo A; Rossini R; Zoccai GB; Messina S; Coscioni E; Romano S; Romano MF
Curr Drug Metab; 2016; 17(2):194-203. PubMed ID: 26652157
[TBL] [Abstract][Full Text] [Related]
15. Incomplete inhibition of platelet aggregation and glycoprotein IIb-IIIa receptor blockade by abciximab: importance of internal pool of glycoprotein IIb-IIIa receptors.
Gawaz M; Ruf A; Pogatsa-Murray G; Dickfeld T; Rüdiger S; Taubitz W; Fischer J; Müller I; Meier D; Patscheke H; Schömig A
Thromb Haemost; 2000 Jun; 83(6):915-22. PubMed ID: 10896249
[TBL] [Abstract][Full Text] [Related]
16. Platelet dysfunction reversal with cold-stored vs room temperature-stored platelet transfusions.
Kogler VJ; Miles JA; Özpolat T; Bailey SL; Byrne DA; Bawcom-Randall M; Wang Y; Larsen HJ; Reed F; Fu X; Stolla M
Blood; 2024 May; 143(20):2073-2088. PubMed ID: 38427589
[TBL] [Abstract][Full Text] [Related]
17. First report of the point-of-care TEG: A technical validation study of the TEG-6S system.
Gurbel PA; Bliden KP; Tantry US; Monroe AL; Muresan AA; Brunner NE; Lopez-Espina CG; Delmenico PR; Cohen E; Raviv G; Haugen DL; Ereth MH
Platelets; 2016 Nov; 27(7):642-649. PubMed ID: 27809712
[TBL] [Abstract][Full Text] [Related]
18. Comparison of the effect of different platelet GPIIb/IIa antagonists on the dynamics of platelet/fibrin-mediated clot strength induced using thromboelastography.
Mousa SA; Forsythe MS
Thromb Res; 2001 Oct; 104(1):49-56. PubMed ID: 11583738
[TBL] [Abstract][Full Text] [Related]
19. Using thrombelastography to determine the efficacy of the platelet glycoprotein IIb/IIIa antagonist, roxifiban, on platelet/fibrin-mediated clot dynamics in humans.
Mousa SA; Bozarth JM; Seiffert D; Feuerstein GZ
Blood Coagul Fibrinolysis; 2005 Apr; 16(3):165-71. PubMed ID: 15795533
[TBL] [Abstract][Full Text] [Related]
20. Desmopressin antagonizes the in vitro platelet dysfunction induced by GPIIb/IIIa inhibitors and aspirin.
Reiter RA; Mayr F; Blazicek H; Galehr E; Jilma-Stohlawetz P; Domanovits H; Jilma B
Blood; 2003 Dec; 102(13):4594-9. PubMed ID: 12920042
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
